Global coronavirus cases surpass 114 million mark


FE Team | Published: March 01, 2021 10:54:24 | Updated: March 01, 2021 17:18:53


Global coronavirus cases surpass 114 million mark

The confirmed cases of coronavirus exceeded 114 million across the globe as of Monday.

The total case count reached 114,051, 765 and the death toll from the virus stood at 2,530,563, according to data compiled by Johns Hopkins University (JHU).

The US, which remained the worst-hit country of the world, has registered 28,605,527 cases  and deaths 513,091 till Monday morning, reports UNB.

The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two, according to AP report.

Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the US and is mutating in increasingly worrisome ways.

Brazil reported 34,027 new COVID-19 cases and 721 related deaths on Sunday, taking the national tally of confirmed cases to 10,551,259 and death toll to 254,942, the Ministry of Health said.

Brazil is ranked second worldwide after the United States in terms of the number of deaths from COVID-19 and third in terms of the number of confirmed cases, after the United States and India.

The country currently registers an average of 121 deaths and 5,021 cases per 100,000 inhabitants, according to the ministry.

The second wave of the coronavirus has caused the health systems of most regional capitals to collapse, forcing regional governments to tighten restrictions and social distancing measures.

As of Saturday, 6.5 million people, or more than 3 percent of the population, have received at least one dose of COVID-19 vaccine, while 1.9 million people had received both doses.

India’s total caseload reached 11,096,731 as of Monday morning while the country’s death toll reached 157,051.

Indian Prime Minister Narendra Modi took his first dose of COVID-19 vaccine, Covaxin, on Monday.

The Covaxin vaccine is manufactured by "Bharat Biotech" company.

Nearly 15 million people have been covered so far in the COVID-19 nationwide vaccination drive, which began on Jan. 16.

Meanwhile, India continues to register over 15,000 daily COVID-19 cases.

Situation in Bangladesh

Bangladesh's daily Covid-19 positivity rate has dropped below 3% after going over the mark for two days.

The daily Covid-19 infection rate was 3.30 per cent on Saturday and 3.13 per cent on Friday.

The country recorded 385 more Covid-19 infections from 13,411 samples tested until early Sunday, resulting in a daily test positivity rate of 2.87 per cent.

With the new infections, 546,216 people have now tested positive for the virus in the country since the start of the pandemic.

Also, the country saw eight new Covid-19 deaths, taking the national tally to 8,408. The fatality rate stood at 1.54 per cent, the Directorate General of Health Services said.

The overall infection rate stood at 13.51 per cent. However, 496,924 patients – 90.98 per cent – have recovered so far.

Covid-19 vaccination drive in Bangladesh

Bangladesh launched a countrywide coronavirus vaccination drive on February 7.

By Sunday, 3,110,525 people had received the first dose of the Oxford-AstraZeneca vaccine. The second dose has to be taken between 8 and 12 weeks of the first one.

The government is providing the vaccine free of cost. It signed an agreement with India's Serum Institute for 30 million doses of the vaccine.

The institute will provide five million doses every month between January and June.

People, who are 40 or above, can register for the vaccine at www.surokkha.gov.bd. The on-spot registration system has been scrapped.

 

Share if you like